MONITORING OF HAEMATOLOGIC, CYTOGENETIC AND MOLECULAR RESPONSES IN CHRONIC MYELOID LEUKEMIA PATIENTS ON TKI THERAPY

被引:0
|
作者
Mahmood, Rafia [1 ]
Malik, Hamid Saeed [1 ,2 ]
Suhail, Maymoona [1 ,2 ]
机构
[1] Armed Forces Inst Pathol, Rawalpindi, Pakistan
[2] Natl Univ Med Sci, Rawalpindi, Pakistan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:61 / 62
页数:2
相关论文
共 50 条
  • [41] Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in China
    Qian Jiang
    Robert Peter Gale
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1549 - 1555
  • [42] EVALUATION OF A CENTRALIZED MOLECULAR MONITORING OF CHRONIC MYELOID LEUKEMIA THERAPY IN SOUTH KOREA
    Choi, S. Y.
    Song, H. Y.
    Oh, Y. J.
    Kim, S. H.
    Lee, E. E.
    Kim, H.
    Kim, Y. S.
    Lee, W. S.
    Kim, S. H.
    Kong, J. H.
    Kim, M. K.
    Lee, S. R.
    Do, Y. R.
    Park, J.
    Jin, Y. Y.
    Joo, Y. D.
    Kim, K. H.
    Ryu, H. M.
    Choi, C. W.
    Oh, S.
    Park, S.
    Kim, J.
    Nam, S. H.
    Yahng, S. A.
    Shin, S. H.
    Won, Y. W.
    Zang, D. Y.
    Kim, J. A.
    Kim, D. W.
    HAEMATOLOGICA, 2015, 100 : 442 - 442
  • [43] Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in China
    Jiang, Qian
    Gale, Robert Peter
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (07) : 1549 - 1555
  • [44] Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia
    Kaeda, J
    Chase, A
    Goldman, JM
    ACTA HAEMATOLOGICA, 2002, 107 (02) : 64 - 75
  • [45] A scoring system to predict molecular responses in patients with chronic myeloid leukemia in the chronic phase receiving initial imatinib therapy
    李子郁
    China Medical Abstracts(Internal Medicine), 2023, 40 (02) : 122 - 123
  • [46] Chronic myeloid leukemia: sequencing of TKI therapies
    Cortes, Jorge
    Kantarjian, Hagop
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 164 - 169
  • [47] Cytogenetic and molecular responses in German patients with chronic-phase chronic myeloid leukemia (CP-CML) in a prospective observational study (SIMPLICITY)
    Repp, R.
    Hehlmann, R.
    Linde, H.
    Reiser, M.
    Tesch, H.
    Foreman, A.
    Schreiner, L.
    Hillig, G.
    Oncology Research and Treatment, 2015, 38 : 132 - 132
  • [48] EARLY CYTOGENETIC AND MOLECULAR RESPONSES AND LONG-TERM OUTCOME IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED WITH NILOTINIB
    Gugliotta, G.
    Castagnetti, F.
    Palandri, F.
    Breccia, M.
    Levato, L.
    Stagno, F.
    Luciano, L.
    Zaccaria, A.
    Rossi, A.
    Usala, E.
    Gozzini, A.
    Carella, A.
    Capucci, A.
    Musto, P.
    Tiribelli, M.
    Abruzzese, E.
    Avanzini, P.
    Soverini, S.
    Bochicchio, M.
    Testoni, N.
    Alimena, G.
    Pane, F.
    Martinelli, G.
    Cavo, M.
    Saglio, G.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA, 2013, 98 : 58 - 58
  • [49] CYTOGENETIC STUDIES IN CHRONIC MYELOID LEUKEMIA
    PADEH, B
    BIANU, G
    AKSTEIN, E
    SCHAKI, R
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1965, 1 (4P2): : 791 - &
  • [50] CYTOGENETIC STUDIES IN CHRONIC MYELOID LEUKEMIA
    BROWN, WMC
    TOUGH, IM
    ADVANCES IN CANCER RESEARCH, 1963, 7 : 351 - 381